Inspire Veterinary Partners Delisted from Nasdaq, Moves to OTCQB Venture Market

summarizeSummary

Inspire Veterinary Partners, Inc. announced its common stock was delisted from The Nasdaq Capital Market and has begun trading on the OTCQB Venture Market following Nasdaq's denial of its appeal.

check_boxKey Events

• Nasdaq Delisting Confirmed

  The Nasdaq Hearings Panel denied the company's appeal to continue its listing, leading to the suspension and delisting of its common stock from The Nasdaq Capital Market as of January 21, 2026.

• Transition to OTCQB Venture Market

  The company's common stock has been approved to trade on the OTCQB Venture Market under the symbol 'IVPR' and commenced trading there on January 21, 2026.

• Continued SEC Reporting

  Inspire Veterinary Partners intends to continue filing periodic and current reports with the U.S. Securities and Exchange Commission.

• Future Business Plans

  The company plans to continue growth of existing locations and prepare for the launch of an online pet pharmacy in the first half of 2026.

auto_awesomeAnalysis

The delisting of Inspire Veterinary Partners from Nasdaq to the OTCQB Venture Market is a critical negative event. This transition typically results in significantly reduced liquidity, lower investor visibility, and can make it substantially more challenging for the company to raise capital in the future. While the company states its intent to continue its business strategy and file SEC reports, the move to an over-the-counter market often signals increased risk and can deter institutional investors. The stock is already trading near its 52-week low, further highlighting the company's distressed financial position.